develop
effect
mucos
vaccin
formul
porcin
epidem
diarrhea
viru
pedv
infect
dna
fragment
encod
spike
protein
immunodomin
region
nucleocapsid
n
pedv
insert
surfacedisplay
secretori
plasmid
follow
electrotransform
lactobacillu
casei
lc
yield
four
recombin
strain
intragastr
administr
observ
live
lcexpress
protein
combin
lcexpress
n
protein
could
elicit
much
potent
mucos
system
immun
respons
former
alon
p
howev
slightli
inferior
latter
alon
p
furthermor
surfacedisplay
mixtur
reveal
stronger
immunogen
secretori
mixtur
well
pedvneutr
potenc
vitro
p
day
last
immun
splenocyt
prepar
mice
immun
surfacedisplay
mixtur
secretori
mixtur
neg
control
stimul
purifi
n
protein
respect
result
elisa
analysi
show
n
protein
capabl
induc
higher
level
p
p
protein
immun
mice
taken
togeth
lcexpress
n
protein
molecular
adjuv
immunoenhanc
abl
effect
facilit
induct
mucos
system
immun
respons
lcexpress
region
porcin
epidem
diarrhea
viru
pedv
caus
lethal
diarrhea
piglet
result
great
econom
loss
world
member
coronavirida
caus
sever
enteropathogen
diarrhea
especi
piglet
pedv
belong
group
coronaviru
consist
pedv
transmiss
gastroenter
viru
tgev
human
coronaviru
vijgen
et
al
felin
coronaviru
fecov
canin
coronaviru
ccv
human
coronaviru
nl
new
baoxian
et
al
van
der
hoek
et
al
pedv
tgev
caus
diseas
character
rather
similar
clinic
symptom
make
rather
difficult
draw
clear
divid
line
replic
differenti
enterocyt
small
intestin
caus
sever
diarrhea
sanchez
et
al
sever
viral
protein
import
induc
immun
respons
pedv
spike
protein
kda
membran
protein
nucleoprotein
n
kda
egberink
et
al
glycoprotein
pedv
possess
immunodomin
region
liyun
et
al
play
crucial
role
earli
step
infect
mediat
bind
viru
cell
surfac
subsequ
fusion
viral
cell
membran
yeo
et
al
duart
laud
pedv
n
protein
form
helic
nucleocapsid
genom
rna
predomin
antigen
produc
coronavirusinfect
cell
thu
make
major
viral
target
therefor
n
protein
sensit
diagnost
antigen
use
develop
specif
sensit
enzymelink
immunosorb
assay
elisa
hou
et
al
rodak
et
al
howev
n
protein
abl
induc
immunoprotect
pedv
infect
owe
envelop
surround
virion
shield
ge
et
al
hou
et
al
lactic
acid
bacteria
lab
long
use
industri
food
ferment
preserv
known
benefici
effect
health
human
anim
consid
generallyregardedassaf
microorgan
pouwel
et
al
claassen
et
al
mani
strain
lab
abl
surviv
colon
intestin
tract
davidson
et
al
mohamadzadeh
et
al
moeini
et
al
fredriksen
et
al
yigang
et
al
lab
use
live
carrier
deliv
model
pathogen
antigen
mucos
surfac
induc
system
mucos
effect
immun
respons
may
prefer
term
safeti
control
minim
side
effect
nonspecif
immunoadjuv
effect
galdeano
perdigon
ogawa
et
al
provok
serial
studi
aim
determin
capabl
feasibl
applic
lab
safe
oral
vaccin
claassen
et
al
pouwel
et
al
maassen
et
al
like
mani
pathogen
pedv
initi
infecti
cycl
mucos
surfac
especi
intestin
mucos
epitheli
surfac
ben
salem
et
al
duart
laud
effici
protect
mucos
infect
requir
develop
new
vaccin
induc
protect
immun
respons
system
level
also
mucos
level
order
inhibit
entri
viru
bodi
mucos
approach
mota
et
al
best
achiev
mucos
vaccin
rout
offer
sever
advantag
tradit
parenter
vaccin
potenti
develop
lactic
acid
bacteria
deliv
heterolog
antigen
mucos
immun
system
propos
mani
properti
make
attract
candid
antigen
deliveri
carrier
present
mucosa
compound
pharmaceut
interest
particular
vaccin
perdign
et
al
merceni
et
al
well
et
al
therefor
develop
novel
effici
vaccin
intragastr
administr
base
lactobacillu
casei
lc
better
formul
immunoprophylaxi
pedv
infect
studi
wellcharacter
pedv
gene
n
outstand
potenti
function
antigen
clone
shuttl
vector
base
xylos
promot
follow
transform
lc
yield
recombin
strain
addit
construct
previous
laboratori
ge
et
al
result
appear
trend
titer
serum
igg
secretori
iga
n
oral
administr
mice
recombin
lc
furthermor
n
protein
induc
splenocyt
immun
mice
yield
higher
level
protein
bacteri
strain
growth
condit
l
casei
atcc
plasmidfre
strain
grown
mr
medium
sigma
without
shake
chloramphenicol
sigma
shanghai
china
util
concentr
clone
plasmid
escherichia
coli
use
studi
grown
lb
medium
contain
ampicillin
plasmid
kindli
gift
prof
jo
seeger
nizo
institut
netherland
plasmid
procedur
eletrotransform
dna
fragment
encod
pedv
spike
protein
immunodomin
region
bp
nucleocapsid
bp
obtain
plasmid
simplen
bamhi
xhoi
digest
insert
correspond
site
plasmid
gener
new
plasmid
anchor
matrixencod
pgsa
deriv
bacillu
subtili
behind
target
gene
type
surfacedisplay
express
ssusp
secret
signal
target
gene
ensur
target
protein
outsid
lc
prepar
electrotransform
compet
l
casei
perform
describ
previous
lee
et
al
briefli
stationari
phase
h
cultur
recipi
l
casei
inocul
inoculum
vv
ml
mr
broth
incub
without
shake
cell
harvest
od
centrifug
min
wash
twice
equal
cultur
volum
icecold
sucrosemagnesium
chlorid
electropor
buffer
smeb
mm
sucros
mm
mgcl
mm
sodium
phosphat
ph
cell
concentr
origin
cultur
volum
icecold
smeb
buffer
plasmid
dna
mix
icecold
bacteri
suspens
suspens
transfer
precool
gene
dispos
cuvett
interelectrod
distanc
cm
singl
electr
puls
v
deliv
gene
biorad
usa
immedi
follow
discharg
suspens
dilut
recoveri
medium
mr
broth
sucros
bacteria
incub
h
allow
recoveri
express
antibiot
resist
marker
plate
mr
agar
supplement
chloramphenicol
taken
togeth
two
novel
recombin
l
casei
construct
design
analysi
express
n
protein
transform
bacteria
grown
overnight
basal
mr
medium
contain
chloramphenicol
cm
supplement
xylos
bacteri
cell
collect
centrifug
min
pellet
wash
twice
steril
phosphatebuff
salin
pb
ph
lyse
beadbeat
biospec
bartlesvil
ok
usa
vigor
shake
cell
debri
centrifug
min
supernat
analyz
via
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
immunoblot
carri
follow
protein
extract
electrotransf
nitrocellulos
membran
blot
develop
use
mous
antippedv
purifi
pedv
serum
previous
prepar
laboratori
dilut
pb
ph
horseradish
peroxidaseconjug
goat
antimous
igg
sigma
util
secondari
antibodi
dilut
visual
chemiluminesc
substrat
reagent
pierc
rockford
il
usa
follow
manufactur
instruct
recombin
l
casei
harbor
empti
plasmid
act
neg
control
name
respect
detect
surfacedisplay
expresson
immunofluoresc
use
describ
previous
cortesperez
et
al
short
cell
cultur
induc
mr
overnight
cell
pellet
sequenti
incub
mous
antippedv
serum
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
invitrogen
secondari
antibodi
analyz
confoc
microscopi
secret
n
protein
express
examin
supernat
overnight
cultur
mr
supplement
xylos
obtain
centrifug
min
supernat
concentr
time
use
centrifug
filter
unit
millipor
billerica
usa
examin
use
sdspage
immunoblot
describ
immun
sampl
collect
group
ten
femal
spf
balbc
mice
week
old
immun
mixtur
mixtur
pb
grown
overnight
basal
mr
medium
contain
cm
supplement
xylos
respect
oral
rout
cell
ml
pb
ph
suspens
administ
three
consecut
day
day
first
booster
second
booster
mice
handl
maintain
strict
ethic
condit
accord
intern
recommend
anim
welfar
day
preimmun
sera
prepar
blood
sampl
collect
tail
vein
fece
mg
directli
obtain
anu
mice
subsequ
suspend
lyse
pb
contain
edtana
overnight
follow
centrifug
min
supernat
store
vagin
ophthalm
nasal
fluid
obtain
wash
respect
organ
three
time
steril
pb
clear
extract
sampl
collect
centrifug
store
analysi
afterward
addit
supplement
proteas
inhibitor
day
intestin
mucu
mice
extract
describ
previous
robinson
et
al
elson
et
al
enzymelink
immunosorb
assay
elisa
plate
coat
overnight
purifi
n
protein
well
block
h
pb
contain
skim
milk
mucos
serum
sampl
serial
dilut
bsa
ad
triplic
incub
h
plate
wash
three
time
pbstween
horseradish
peroxidaseconjug
goat
antimous
igg
iga
antibodi
invitrogen
ad
well
incub
addit
h
anoth
round
wash
color
develop
carri
use
ophenylenediamin
dihydrochlorid
substrat
absorb
measur
nm
sera
mucos
sampl
balbc
mous
receiv
recombin
lc
pb
blank
control
background
endpoint
titer
defin
highest
dilut
gave
absorb
two
time
higher
background
intestin
fluid
serum
sampl
mice
immun
six
kind
recombin
strain
express
n
evalu
use
plaqu
reduct
assay
determin
neutral
abil
induc
antibodi
accord
method
describ
hou
et
al
brief
lavag
sera
nonexpressor
fed
mice
use
neg
control
fifti
microlit
sampl
twofold
serial
dilut
prepar
microcentrifug
tube
pedv
adjust
pfuml
viru
diluent
ad
tube
contain
serial
dilut
serum
intestin
lavag
antibodi
viru
mixtur
mix
puls
centrifug
incub
h
plate
confluent
monolay
vero
cell
use
viru
infect
inocul
antibodyviru
mixtur
anoth
h
rock
interv
inoculum
remov
overlay
medium
equal
volum
concentr
cell
cultur
medium
contain
carboxylmethyl
cellulos
plate
incub
co
incub
day
iga
igg
pedv
posit
control
kindli
provid
prof
liyun
yu
china
iga
igg
neutral
inhibitori
rate
calcul
describ
previous
hou
et
al
overlay
medium
discard
well
wash
three
time
steril
pb
ph
stain
crystal
violet
solut
experi
perform
twice
statist
comparison
made
studentsttest
cytokin
elisa
week
postimmun
spleen
cell
cultur
upon
stimul
concanavalin
con
solubl
purifi
n
protein
co
supernat
fluid
collect
h
assay
assay
perform
use
elisa
kit
accord
manufactur
instruct
biosourc
intern
camarillo
ca
usa
cytokin
concentr
calcul
accord
standard
curv
obtain
elisa
plate
data
geometr
mean
mice
per
group
repres
duplic
experi
error
bar
repres
standard
deviat
result
express
mean
standard
deviat
sd
p
valu
less
determin
studentsttest
consid
signific
overnight
cultur
induc
basal
mr
supplement
xylos
pellet
cell
lysat
analyz
sdspage
immunoblot
show
ca
fusion
protein
cell
lysat
induc
xylos
fig
lane
fig
lane
immunofluoresc
reaction
induc
xylos
develop
mous
serum
fitcconjug
goat
antimous
igg
also
show
green
fluoresc
cell
surfac
fig
fig
n
protein
secretori
express
l
casei
cell
lysat
supernat
overnight
cultur
basal
mr
medium
addit
xylos
obtain
centrifug
subject
sdspage
immunoblot
examin
target
protein
express
immunoreact
band
ca
kda
detect
cell
lysat
fig
lane
supernat
fig
lane
wherea
band
neg
control
lane
fig
lane
result
demonstr
pedv
nucleocapsid
abl
induc
xylos
l
casei
atcc
balbc
mice
immun
oral
recombin
lc
neg
blank
control
mice
immun
pb
data
shown
respect
mucos
respons
investig
measur
antin
siga
level
fece
vagin
nasal
ophthalm
lavag
fluid
intestin
mucu
postintragastr
immun
via
elisa
level
specif
igg
antin
sera
experiment
mice
indic
system
immun
respons
induc
recombin
lc
concentr
siga
igg
antibodi
express
titer
determin
express
test
sampl
standard
curv
gener
serial
dilut
commerci
purchas
iga
igg
sigma
known
concentr
sinc
day
first
immun
higher
level
iga
specif
could
observ
anim
group
receiv
mixtur
four
kind
sampl
includ
nasal
fece
ophthalm
vagin
lavag
fluid
fig
significantli
differ
group
receiv
p
p
p
p
p
p
p
p
p
p
respect
analysi
sera
obtain
anim
reveal
anim
display
higher
level
iga
also
display
higher
level
igg
fig
show
correl
product
two
kind
antibodi
day
obviou
trend
titer
iga
intestin
mucu
fig
howev
higher
level
iga
igg
specif
n
induc
fig
trend
observ
intestin
mucu
iga
titer
day
fig
level
igg
iga
anim
group
show
signific
differ
first
immun
preimmun
contrast
might
expect
signific
elicit
antibodi
observ
neg
blank
control
data
shown
plaqu
reduct
assay
perform
detect
whether
antibodi
respons
pedv
result
demonstr
presenc
iga
igg
cultur
medium
confer
statist
signific
neutral
effect
p
pedv
infect
consist
observ
antibodi
respons
mice
oral
immun
mixtur
display
stronger
pedvneutr
activ
lcexpress
fourfold
dilut
sera
fig
intestin
lavag
fluid
fig
exhibit
reduct
number
plaqu
surprisingli
neutral
activ
observ
sera
mice
receiv
elisa
result
obtain
cultur
supernat
harvest
h
show
respons
n
spleen
cell
group
produc
higher
level
cytokin
fig
cytokin
fig
p
p
p
pb
p
data
shown
addit
result
show
n
protein
capabl
induc
higher
level
p
p
protein
pedv
caus
acut
enter
pig
death
rate
infect
piglet
lead
signific
econom
loss
swine
husbandri
de
arriba
et
al
yeo
et
al
shown
western
blot
analysi
fig
immunofluoresc
analysi
surfacedisplay
express
l
casei
green
fluoresc
surfac
b
immunofluoresc
reaction
cell
surfac
rout
antigen
deliveri
includ
conveni
costeffect
induct
mucos
system
immun
respons
shaw
et
al
seeger
xin
et
al
mannam
et
al
lee
et
al
goal
provid
first
line
defens
effect
elimin
pathogen
mucos
surfac
sever
studi
focus
surfacedisplay
express
system
base
bacteria
ge
et
al
hou
et
al
lee
et
al
howev
surfac
display
antigen
bacteri
surfac
problemat
larg
antigen
perturb
membran
topolog
true
surfac
exposur
antigen
requir
transmenbran
anchor
long
enough
cross
cell
wall
lee
et
al
least
amino
acid
need
properli
cross
cell
wall
leenhout
et
al
report
develop
surfac
display
system
use
polygammaglutam
synthetas
protein
pgsa
transmembran
anchor
present
heterolog
protein
lc
adapt
pgsa
deriv
pgsbca
enzym
complex
b
subtili
isol
chungkookjang
tradit
korean
soybean
past
use
food
addit
mucos
deliveri
vaccin
induc
mucos
immun
effici
parenter
immun
mutwiri
et
al
surfac
respiratori
gastrointestin
urogenit
tract
cover
skin
refer
mucosa
butler
total
mucosa
cover
area
time
larger
skin
larg
area
resist
penetr
skin
often
limit
thin
epitheli
layer
without
keratin
number
pathogen
initi
infect
mucos
surfac
mucos
surfac
particularli
respiratori
digest
tract
expos
daili
wide
varieti
foreign
organ
antigen
addit
immunoglobulin
iga
primari
immunoglobulin
isotyp
induc
mucos
surfac
secretori
iga
siga
mucos
secret
provid
day
post
immun
iga
concentr
iga
concentr
iga
concentr
igg
concentr
valu
mean
deviat
three
replic
per
treatment
one
experi
repeat
twice
p
protect
bacteri
viral
pathogen
neutral
microbi
toxin
zhang
et
al
yigang
yije
thu
must
effect
deal
larg
amount
foreign
antigen
mucosa
associ
lymphoid
tissu
attract
target
vaccin
strategi
harbor
earli
stage
infect
ogra
et
al
observ
support
concept
mucos
immun
system
mucos
situat
iga
igg
plasma
cell
progenitor
stimul
select
mucos
immun
predict
mucos
immun
provok
mucos
circul
antibodi
respons
better
parenter
immun
heritag
et
al
report
develop
recombin
l
casei
lc
anchor
pedv
spike
protein
immunodomin
region
secret
nucleocapsid
protein
respect
correspond
recombin
strain
ge
et
al
construct
previou
work
lcexpress
lcexpress
n
mixtur
equal
part
lcexpress
lcexpress
n
use
vaccin
mice
via
oral
rout
respect
although
amount
lcexpress
mixtur
half
much
lcexpress
alon
oral
administr
much
higher
level
igg
serum
iga
mucu
specif
protein
elicit
mixtur
consist
pedv
neutral
activ
reflect
plaqu
reduct
assay
howev
antibodi
respons
specif
n
protein
induc
mixtur
inferior
lcexpress
n
view
abovement
fact
could
specul
n
protein
seem
play
crucial
role
product
higherlevel
antibodi
mixtur
protein
subsequ
observ
secretori
level
splenocyt
isol
mice
immun
mixtur
stimul
n
protein
obvious
higher
protein
theoret
could
effect
advanc
prolif
differenti
b
cell
plasma
cell
secret
larg
amount
antibodi
import
member
cytokin
vital
role
play
direct
immun
respons
regul
immun
network
especi
aspect
antiviru
effect
describ
undoubtedli
logic
mixtur
induc
higher
valu
mean
deviat
three
replic
per
treatment
one
experi
repeat
twice
p
antibodi
respons
protein
theori
could
inhibit
pathway
secret
downregul
howev
result
show
togeth
induc
n
make
rel
balanc
greater
amount
demonstr
respons
lead
one
target
protein
express
complet
depend
xylos
induct
studi
owe
l
casei
express
system
base
xylos
operon
regul
accord
statement
induc
recombin
strain
abl
stimul
mucos
immun
system
gastrointestin
tract
sever
day
lifetim
oral
administr
mice
result
immunotoler
target
antigen
induc
recombin
bacteria
colon
mucos
surfac
although
xylos
present
target
protein
still
keep
secretori
transmembran
state
host
cell
recogn
process
present
relev
lymphocyt
mucos
immun
system
could
induc
local
immun
respons
perform
comparison
immunogen
surfacedisplay
secretori
recombin
strain
inocul
mice
via
intragastr
rout
statist
signific
differ
observ
sinc
seventh
day
first
immun
far
antigen
concern
recombin
lc
greater
lc
induct
antibodi
immun
respons
conspicu
event
studi
premis
bacteri
amount
quantiti
antigen
anchor
surfac
lc
far
larger
lc
data
shown
recombin
lc
colon
mucos
surfac
gastrointestin
tract
lc
secret
antigen
extern
milieu
addit
lc
lc
induc
express
system
base
xylos
operon
could
keep
sustain
express
target
protein
summari
recombin
lc
possess
stronger
immunogen
moreov
tri
fusion
protein
express
lc
fail
use
variou
promot
indic
everi
gene
express
effici
host
organ
conclus
demonstr
nucleocapsid
protein
pedv
display
surfac
l
casei
abl
reinforc
surfacedisplay
elicit
higher
level
system
mucos
immun
respons
although
antibodi
neutral
pedv
take
difficult
express
whole
protein
pedv
l
casei
consider
oral
vaccin
induc
neutral
antibodi
must
includ
protein
immunodomin
region
ho
et
al
junwei
et
al
liyun
et
al
success
immun
respons
antigen
necessari
antigen
present
suffici
quantiti
form
recogn
antigenpres
cell
immun
system
consequ
l
casei
suitabl
act
mucos
vaccin
carrier
gastrointestin
tropism
pathogen
although
balbc
mous
genuin
suscept
anim
inhibit
fig
antibodi
neutral
activ
pedv
vitro
serum
b
intestin
mucu
prepar
mice
immun
result
mean
valu
standard
error
triplic
model
pedv
result
studi
least
indic
l
casei
surfacedisplay
combin
l
casei
surfacedisplay
n
could
act
novel
mucos
vaccin
formul
may
present
signific
opportun
pedv
vaccin
develop
recent
sever
year
develop
oral
vaccin
base
lactic
acid
bacteria
deliveri
vehicl
made
great
stride
combin
knowledg
differ
disciplin
virolog
molecular
biolog
immunolog
bioinformat
ecolog
epidemiolog
even
greater
progress
expect
made
toward
understand
import
live
bacteri
carrier
underli
principl
mucos
vaccin
therein
collin
schodel
elucid
character
physic
structur
chemic
composit
bioinform
bacteri
cell
wall
surfac
protein
provid
new
challeng
opportun
allow
us
better
understand
interact
intestin
lactobacilli
mucos
tissu
recent
develop
molecular
biolog
techniqu
could
permit
construct
lactic
acid
bacteriapres
foreign
antigen
expos
differ
immun
organ
first
time
make
opportunist
explor
potenti
safe
food
bacteria
vaccin
vehicl
gentschev
et
al
spite
rapid
concurr
develop
relat
knowledg
techniqu
problem
must
solv
first
commerci
mucos
vaccin
base
lactic
acid
bacteria
come
although
possibl
determin
rel
accur
level
express
antigen
test
tube
precis
monitor
gene
express
gastrointestin
tract
therefor
necessari
develop
novel
method
analyz
express
gene
encod
antigen
situ
control
effici
persist
express
addit
optim
proport
lcexpress
lcexpress
n
mixtur
yield
better
immun
efficaci
long
could
recombin
bacteria
persist
gastrointestin
tract
remain
need
research
